Letters

;

CMS responds to request for information regarding reporting on pharmacy benefits and prescription drug costs

Feb 17, 2022

On behalf of the Centers for Medicare & Medicaid Services (CMS), thank you for the letter regarding the Request for Information (RFI) Regarding Reporting on Pharmacy Benefits and Prescription Drug Costs1. The 58 organizations that signed this correspondence are the voice for many individuals who rely on affordable prescription drugs to treat their health conditions and prevent others, and we appreciate hearing from you on this important issue.

read more

Comments on the USPSTF draft research plan “Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis”

Dec 6, 2021

We urge the USPSTF to consider the following two recommendations as it finalizes its plan “Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis”: research should explicitly evaluate and describe the ancillary services that are integral to the PrEP intervention and the USPSTF should adopt a more nimble and timely review of the PrEP recommendation as new products see clinical trial success.

read more

Letter in support of the “PrEP Assistance Program Act”

Nov 23, 2021

PrEP is a critical component to ending the HIV epidemic; however, its uptake has been limited, particularly in communities most at risk of HIV, including Black and Latino gay men and Black women. While there are established government programs that are funded for the treatment of HIV, there is no comprehensive nationwide program dedicated for the provision of PrEP. The “PrEP Assistance Program Act” would help fill that void by providing grants to states, community-based organizations, community health centers, and others to establish and support PrEP programs.

read more

Search

Categories

Tags

ACA Appropriations Biden administration CDC co-pay accumulators Congress copay copay accumulator Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B hepatitis C Hepatitis Prevention HHS HIV HIV Prevention Insurers Medicaid medicare Medicare Part D NAIC NIH PBM PBMs PrEP Prescription Drugs Private Insurance Ryan White Program state STDs Syringe services Testing transparency Treatment Trump administration women

Recent Testimony, Letters, Comments

Pin It on Pinterest